Simplex Trading’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-9,491
Closed -$42.8K 9847
2024
Q1
$50K Buy
9,491
+1,394
+17% +$6.56K ﹤0.01% 6263
2023
Q4
$34K Buy
8,097
+7,915
+4,349% +$24.3K ﹤0.01% 6463
2023
Q3
$0 Sell
182
-609
-77% -$3.99K ﹤0.01% 9857
2023
Q2
$8K Buy
+791
New +$8.38K ﹤0.01% 7621
2023
Q1
Sell
-4,770
Closed -$54.5K 10157
2022
Q4
$44K Sell
4,770
-1,136
-19% -$16K ﹤0.01% 6039
2022
Q3
$85K Buy
5,906
+1,110
+23% +$16.5K ﹤0.01% 5747
2022
Q2
$63K Buy
+4,796
New +$65.3K ﹤0.01% 6190

Other funds holding TSVT

Simplex Trading's TSVT Position: Q2 2024 in Review

Simplex Trading sold out of 2seventy bio (TSVT) in Q2 2024, closing a stake of 9,491 shares — an estimated $42.8K sold.

Simplex Trading first reported a position in TSVT in Q2 2022 and held it in 7 quarters. The position peaked at $85K in Q3 2022. 115 funds tracked by Wall St. Rank hold TSVT as of Q2 2024.

  • Simplex Trading reported no remaining 2seventy bio position as of Q2 2024 after selling out during the quarter.
  • Simplex Trading sold 9,491 2seventy bio shares in Q2 2024, an estimated $42.8K.
  • Simplex Trading first reported a position in 2seventy bio in Q2 2022 and held it in 7 quarters.
  • Simplex Trading's 2seventy bio position peaked at $85K in Q3 2022.
  • 115 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2024.

Based on Simplex Trading's 13F filing for Q2 2024, filed 25 Jul 2024.